Overview
Hidehiro Mizusawa practices practicing medicine in Kodaira, Japan.
Their clinical expertise encompasses Kuru, Spinocerebellar Ataxia Type 31, Creutzfeldt-Jakob Disease, and Hereditary Ataxia.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hidehiro Mizusawa
Is Hidehiro Mizusawa a top-rated expert for Kuru?
MediFind is an objective health platform that identifies experts based on real-world data. Hidehiro Mizusawa is classified as an Experienced expert for Kuru, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hidehiro Mizusawa participate in research or clinical trials?
Yes. Hidehiro Mizusawa has published 7 articles and abstracts on conditions like Kuru. You can view a list of Hidehiro Mizusawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Creutzfeldt-Jakob DiseaseMizusawa isExperienced. Learn about Creutzfeldt-Jakob Disease.
- Hereditary AtaxiaMizusawa isExperienced. Learn about Hereditary Ataxia.
- KuruMizusawa isExperienced. Learn about Kuru.
- Spinocerebellar Ataxia Type 31Mizusawa isExperienced. Learn about Spinocerebellar Ataxia Type 31.